Tag: iVascular
Luminor drug-coated balloon launched in Japan
iVascular has announced that its Luminor drug-coated balloon (DCB) is now available in Japan.
“This approval from the MHLW is evidence of the quality,...
Two-year iVolution Pro registry data presented at LINC 2025
iVascular has shared that Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented the results of an observational and prospective registry on the use...
TINTIN trial subanalyses presented at LINC 2025
Koen Deloose (AZ Sint Blasius Hospital, Dendermonde, Belgium) presented new sub-cohort analyses from the TINTIN trial at this year's Leipzig Interventional Course (LINC 2025;...
iVascular announces first data from BARISTA trial of Restorer BMS in...
iVascular has announced the first clinical outcomes of the Restorer bare metal stent (BMS) in iliac artery treatment.
The data were presented earlier this...
Vascular News’ top 10 most popular stories of July 2024
Several company updates including Series A funding for Endoron Medical, new insights on the role of machine learning in determining endovascular aneurysm repair (EVAR)...
First results of SOL Japan highlight “extraordinary performance” of Luminor DCB...
iVascular has announced that "outstanding" results from the SOL Japan study were recently presented at the Japan Endovascular Treatment (JET) conference (14–16 June, Fukuoka,...
iCover’s radiopaque markers and full encapsulation with small profiles help it...
Vicente Riambau (Barcelona, Spain) describes the unique features and improvements of the iCover balloon expandable covered stent, notably its low profile, radiopaque markers, and...
Five-year RCT data provide upbeat message on Luminor paclitaxel-coated balloon’s safety...
NOTE: This video is ONLY available to watch in selected countries and geographies
The EffPac trial was a prospective, multicentre, randomised controlled trial (RCT)...
New TINTIN data indicate longer term success of DCB and stent...
NOTE: This video is ONLY available to watch in selected countries and geographies
The combined use of a drug-eluting device and a vascular scaffold...
EffPac trial highlights “amazing five-year results” for Luminor DCB
NOTE: This video is ONLY available to watch in selected countries and geographies
Ulf Teichgräber (Jena, Germany) talks to Vascular News at the Cardiovascular and Interventional...
iVascular announces first patients enrolled in BARISTA clinical trial
iVascular recently announced the first patient enrolment in the BARISTA study, a Belgian physician-initiated study to assess the efficacy and safety of the company's...
Vascular News’ top 10 most popular stories of May 2022
Two-year data on the use of intravascular lithotripsy (IVL) in calcified peripheral disease treatment, an advertorial sponsored by Bentley exploring the role of bridging...
iVascular receives CE mark for iCover covered stent
iVascular has received CE mark approval for its balloon-expandable covered stent, iCover, a press release from the company states.
Balloon-expandable covered stents are commonly used...
Episode 1: Luminor DCB in the femoropopliteal segment: Outstanding safety and...
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Episode 2: Experience of Luminor DCB in the below-the-knee segment
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
Episode 3: Not all DCBs are the same: Luminor TransferTech nanotechnology...
NOTE: This video is ONLY available to watch in selected countries and geographies
Koen Deloose (Dendermonde, Belgium) moderates a three-part Vascular News series about the Luminor...
“No signal of increased risk of long-term mortality” with paclitaxel-coated Luminor...
An ad hoc, two-year analysis of the EffPac study found no signal of increased risk of long-term mortality, nor any adverse events, within two...
iVascular launches Sergeant peripheral support catheter
iVascular recently announced the launch of its Sergeant peripheral support catheter. Sergeant is a CE marked over-the-wire catheter, indicated for patients with peripheral arterial...
MERLION trial six-month outcomes presented at VIVA late-breaking trial session
Six-month clinical outcomes of the MERLION trial were presented as part of the VIVA Late-Breaking Clinical Trials Livesteam (25 June), by Tjun Tang (Singapore...
Luminor DCB now reimbursed in France
It was recently announced that luminor 18 and luminor 35 DCBs (iVascular), are now listed on the French LPPR list for de novo lesions...
Experts discuss latest results from EFFPAC and TINTIN trials presented at...
NOTE: ONLY intended for healthcare professionals outside of the USA.
Ulf Teichgräber (Jena, Germany) and Koen Deloose (Dendermonde, Belgium) discuss the 24-month results of the...
TINTIN trial shows “impressive” results at six months
The six-month results of TINTIN (Treatment with the lumINor DCB and The IVolutioN self-expanding stent) trial have been revealed at the annual meeting of the Cardiovascular and...
Enrolment complete in T.I.N.T.I.N. study
iVascular has announced the completion of enrolment of patients in its T.I.N.T.I.N. (Treatment with the Luminor DCB and the iVolution self-expanding stent) study.
The effectiveness...
CX 2018: Ulf Teichgräber discusses EffPAC trial 12-month results
Ulf Teichgräber, Jena, Germany, discusses the EffPAC trial 12-month results which were presented for the first time at CX 2018
iVascular initiates TINTIN Luminor trial
iVascular SLU has announced the initiation of the TINTIN trial, evaluating the combined therapy of Luminor drug-coated balloon (DCB) and iVolution self-expandable stent.
The TINTIN...
iVascular SLU receives Indian clearance for peripheral products
iVascular SLU has announced that it has received approval for selling its coronary and peripheral products in India.
The Indian medical devices market is the...
Luminor drug-coated balloon receives Canadian Medical Device Licence
iVascular has announced that its Luminor 14m peripheral balloon catheter with paclitaxel elution has received the Canadian Medical Device Licence (MDL).
Luminor 14m is a...
Luminor EffPAC study shows efficacy at six months
Data have been announced demonstrating the efficacy of iVascular’s Luminor drug-coated balloon (DCB) in patients with peripheral artery disease (PAD) at six months. The...
Angiolite BTK below-the-knee sirolimus-eluting stent receives CE mark approval
iVascular has announced the release of Angiolite BTK, a sirolimus-eluting stent which has received CE mark approval for treating chronic and acute arterial lesions in...
Capturer 7F thrombus extraction catheter receives CE mark
iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F.
A company press release states that Capturer 7F has “outstanding extraction capacity” and “the...
LUMINOR Registry may help “reopen the door” for drug-coated balloons below...
The LUMINOR Registry is a real-world prospective multicentre study evaluating iVascular’s Luminor paclitaxel-eluting balloon for treating advanced limb ischaemia. Vascular News spoke to Vincent...
